B.Riley FBR Sticks to Its Buy Rating for NGM Biopharmaceuticals (NGM)

 

B.Riley FBR Sticks to Its Buy Rating for NGM Biopharmaceuticals (NGM)

Mamtani covers the Healthcare sector, focusing on stocks such as Spring Bank Pharmaceuticals, Arrowhead Pharmaceuticals, and Spectrum Pharmaceuticals. Currently, the analyst consensus on NGM …

More B.Riley FBR Sticks to Its Buy Rating for NGM Biopharmaceuticals (NGM) Videos

Leave a Reply